Ha Tay Pharmaceutical JSC (HNX:DHT)
Vietnam
· Delayed Price · Currency is VND 86,600
+400 (0.46%)
At close: Aug 15, 2025
Ha Tay Pharmaceutical JSC Ratios and Metrics
Market cap in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Aug '25 Aug 14, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 7,130,667 | 7,822,325 | 1,893,826 | 1,027,245 | 1,188,329 | 1,126,008 | Upgrade
|
| Market Cap Growth | 54.72% | 313.04% | 84.36% | -13.56% | 5.54% | 9.67% | Upgrade
|
| Enterprise Value | 7,355,186 | 8,001,132 | 2,176,376 | 1,106,314 | 1,073,555 | 1,287,133 | Upgrade
|
| Last Close Price | 86600.00 | 95000.00 | 22370.14 | 13512.40 | 14889.78 | 17636.11 | Upgrade
|
| PE Ratio | 97.77 | 108.99 | 22.27 | 10.79 | 17.49 | 12.23 | Upgrade
|
| PS Ratio | 3.31 | 3.75 | 0.95 | 0.56 | 0.74 | 0.56 | Upgrade
|
| PB Ratio | 6.53 | 7.40 | 1.78 | 1.29 | 1.58 | 3.22 | Upgrade
|
| P/TBV Ratio | 6.71 | 7.61 | 1.83 | 1.33 | 1.63 | 3.47 | Upgrade
|
| P/FCF Ratio | - | - | - | - | - | 205.99 | Upgrade
|
| P/OCF Ratio | 74.10 | 279.78 | 6.99 | - | - | 11.92 | Upgrade
|
| EV/Sales Ratio | 3.41 | 3.84 | 1.09 | 0.60 | 0.67 | 0.64 | Upgrade
|
| EV/EBITDA Ratio | 70.92 | 82.49 | 18.71 | 9.23 | 13.64 | 10.49 | Upgrade
|
| EV/EBIT Ratio | 91.21 | 104.57 | 21.94 | 10.80 | 17.30 | 11.76 | Upgrade
|
| EV/FCF Ratio | -396.57 | - | - | - | - | 235.46 | Upgrade
|
| Debt / Equity Ratio | 0.39 | 0.45 | 0.47 | 0.42 | 0.38 | 0.58 | Upgrade
|
| Debt / EBITDA Ratio | 4.47 | 4.85 | 4.33 | 2.81 | 3.68 | 1.66 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | - | 37.35 | Upgrade
|
| Asset Turnover | 1.15 | 1.11 | 1.21 | 1.36 | 1.49 | 2.42 | Upgrade
|
| Inventory Turnover | 3.96 | 4.12 | 4.28 | 4.12 | 4.08 | 4.92 | Upgrade
|
| Quick Ratio | 0.44 | 0.41 | 0.81 | 0.47 | 1.18 | 0.59 | Upgrade
|
| Current Ratio | 1.22 | 1.21 | 1.69 | 1.80 | 2.10 | 1.30 | Upgrade
|
| Return on Equity (ROE) | 7.25% | 7.08% | 9.54% | 12.75% | 12.95% | 29.05% | Upgrade
|
| Return on Assets (ROA) | 2.37% | 2.54% | 3.75% | 4.73% | 3.60% | 8.26% | Upgrade
|
| Return on Capital (ROIC) | 3.03% | 3.09% | 4.58% | 5.88% | 4.86% | 13.30% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.00% | 6.60% | 8.00% | 11.30% | 8.20% | 30.90% | Upgrade
|
| Earnings Yield | 1.02% | 0.92% | 4.49% | 9.27% | 5.72% | 8.18% | Upgrade
|
| FCF Yield | -0.26% | -1.47% | -5.05% | -27.84% | -7.05% | 0.48% | Upgrade
|
| Dividend Yield | 1.16% | - | - | - | 2.40% | - | Upgrade
|
| Payout Ratio | 53.50% | 111.73% | - | 53.87% | 29.96% | 48.22% | Upgrade
|
| Buyback Yield / Dilution | - | -62.83% | - | - | - | - | Upgrade
|
| Total Shareholder Return | 1.18% | -62.83% | - | - | 2.40% | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.